Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 262 | 646 | -457 | 364 | 230 |
| Cost of Goods | N/A | 371 | N/A | 319 | 258 |
| Gross Profit | 262 | 275 | 367 | 45 | -29 |
| Operating Expenses | 4,902 | 7,326 | -1,787 | 6,579 | 6,859 |
| Operating Income | -4,640 | -6,680 | 1,329 | -6,215 | -6,629 |
| Interest Expense | 0 | 126 | 0 | 0 | 0 |
| Other Income | 15 | 72 | 94 | 147 | 228 |
| Pre-tax Income | -4,624 | -6,734 | 1,424 | -6,068 | -6,401 |
| Net Income Continuous | -4,624 | -6,734 | 1,424 | -6,068 | -6,401 |
| Net Income Discontinuous | -2,010 | N/A | N/A | N/A | N/A |
| Net Income | $-6,635 | $-6,734 | $-7,013 | $-6,068 | $-6,401 |
| EPS Basic Total Ops | -3.00 | -3.20 | -3.20 | -3.00 | -3.20 |
| EPS Basic Continuous Ops | -2.20 | -3.31 | 0.89 | -2.97 | -3.13 |
| EPS Basic Discontinuous Ops | -0.80 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.00 | -3.20 | -3.20 | -3.00 | -3.20 |
| EPS Diluted Continuous Ops | -2.20 | -3.31 | 0.89 | -2.97 | -3.13 |
| EPS Diluted Discontinuous Ops | -0.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,250 | $-6,325 | $1,668 | $-5,971 | $-6,334 |